Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for SNDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.1683M
March 31, 2026 -8.286M
December 31, 2025 -2.649M
September 30, 2025 7.316M
June 30, 2025 -6.976M
March 31, 2025 11.47M
December 31, 2024 -32.21M
September 30, 2024 -17.07M
June 30, 2024 -0.9659M
March 31, 2024 -1.243M
December 31, 2023 -5.973M
September 30, 2023 -0.7602M
June 30, 2023 -6.705M
March 31, 2023 -4.781M
December 31, 2022 -7.691M
Date Value
September 30, 2022 -52.38M
June 30, 2022 -27.38M
March 31, 2022 -82.09M
December 31, 2021 -62.62M
September 30, 2021 -165.73M
June 30, 2021 -140.55M
March 31, 2021 -24.91M
December 31, 2020 -40.33M
September 30, 2020 -1.792M
June 30, 2020 -2.904M
March 31, 2020 -9.355M
December 31, 2019 -25.39M
September 30, 2019 -97.85M
June 30, 2019 -21.57M
March 31, 2019 -16.66M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
CannaPharmaRx, Inc. -0.0551M
Bakhu Holdings Corp. --
SpeakEasy Cannabis Club Ltd. --
Tilray Brands, Inc. -51.39M
Clearmind Medicine, Inc. -0.6541M